Cost and utilization of immunotherapy and targeted therapy for melanoma: Cross-sectional analysis in the Medicare population, 2013 and 2015 - 11/02/20
Doi : 10.1016/j.jaad.2019.10.023
Kira Seiger, BA a, b, c, Chrysalyne D. Schmults, MD, MSCE c, Ann W. Silk, MD, MS d, Emily Stamell Ruiz, MD, MPH c, ⁎ 
a Harvard Medical School, Boston, Massachusetts
b Harvard Business School, Boston, Massachusetts
c Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
d Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
∗Reprint requests: Emily Stamell Ruiz, MD, MPH, Department of Dermatology, Brigham and Women's Hospital, 1153 Centre St, Ste 4J, Jamaica Plain, MA 02130Department of DermatologyBrigham and Women's Hospital1153 Centre StSte 4JJamaica PlainMA02130
| Funding sources: Supported in part by the Department of Dermatology at Brigham and Women's Hospital. No sponsor was involved. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Exempt by the Partners Human Research Committee. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 3
P. 761-764 - mars 2020 Retour au numéro
Article précédent
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
- Mayumi Nagata, Masahiro Kamata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Kazumitsu Sugiura, Yayoi Tada
- Risk of acute infections in patients with psoriasis: A nationwide population-based cohort study
- Bo Ri Kim, Danbee Kang, Minwoong Kang, Sungkeun Shim, Chang Kyung Kang, Dong Wook Kim, Eliseo Guallar, Juhee Cho, Sang Woong Youn
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?